Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in Intensity-modulated Radiation Treatment for Head and Neck Cancer

NCT05539144 is registered in ClinicalTrials.gov with Hebei Provincial Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT05539144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05539144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in Intensity-modulated Radiation Treatment for Head and Neck Cancer
Lead sponsor
Hebei Provincial Hospital of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2021
Completion date
December 11, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, oropharynx abnormality, radiotherapy, radiotherapy; adverse effect